National Ovarian Cancer Coalition
Support. Awareness. Cure.
The mission of the NOCC is to save lives through the prevention and cure of ovarian cancer and to improve the quality of life for survivors and their caregivers.
Nearly 22,000 women in the United States are diagnosed with ovarian cancer each year, and approximately 14,000 women die from the disease. Unfortunately, most cases are diagnosed in later stages when the prognosis is poor. However, if diagnosed and treated early when the cancer is confined to the ovary, the five-year survival rate is over 90 percent. This is why it’s imperative that the early signs and symptoms are recognized not only by women, but by their families and the healthcare community.
Early awareness is key
There is no early detection test for ovarian cancer; a Pap test cannot detect the disease. So, women need to know their bodies, be aware of the signs and take early action.
Through national programs and local NOCC market initiatives, our goal is to educate communities and increase awareness about the symptoms of ovarian cancer. The NOCC also provides information to assist newly-diagnosed patients, gives hope to survivors and supports caregivers. Our commitment extends to the advancement of ovarian cancer research.
Our programs are possible only with the help of our staff and volunteers – committed men and women in communities nationwide who are dedicated to the mission of the NOCC. We encourage you to join them. Together, we can make a difference in the lives of women, families, and communities touched by ovarian cancer.
Statistics from the American Cancer Society show:
- In 2022, it is estimated that 19,880 cases of ovarian cancer will be diagnosed
- An estimated 12,810 women will lose their lives to ovarian cancer this year
- The risk of a woman getting ovarian cancer is about 1 in 78 in her lifetime
- Ovarian cancer ranks fifth in cancer deaths among women and causes more deaths than any other gynecological cancer
- The five-year survival rate is over 93% when ovarian cancer is diagnosed and treated in its earliest stages
- Only 20% of all cases are found early, meaning in stage I or II; if the cancer is caught in stage III or higher, the survival rate can be as low as 30%